Personas / Equipo Humano

Ignacio Aznar Lou

Buscador de publicaciones

Publicaciones

  • Gil MM, Aznar I, Peñarrubia-María MT, Moreno-Peral P, Fernández A, Bellón JÁ, Jové AM, Mendive JM, Fernández-Vergel R, Figueiras A, March MA and Rubio-Valera M.

    Reasons for medication non-initiation: A qualitative exploration of the patients' perspective.

    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY . 16(5): 663-672. Nº de citas: 15

    [doi:10.1016/j.sapharm.2019.08.002]

  • Elizabeth Parody-Rúa, Rubio-Valera M, César Guevara-Cuellar, Ainhoa Gómez-Lumbreras, Marc Casajuana-Closas, Carbonell-Duacastella, C and Aznar I.

    Economic Evaluations Informed Exclusively by Real World Data: A Systematic Review.

    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH . 17(4): 1171. Nº de citas: 11

    [doi:10.3390/ijerph17041171]

  • Carbonell Duacastella, Cristina, Aznar I, Gil MM, Peñarrubia-María MT, Gallardo C, Planchuelo D, Jiménez B, March MA and Rubio-Valera M.

    Estat actual de la recerca sobre la no-iniciació a nivell mundial i a Catalunya

    Circular Farmaceutica . 77(3): 17-20.

  • Aznar I, Carbonell, C., Rodríguez A, Mera I and Rubio-Valera M.

    Prevalence of Medication-Dietary Supplement Combined Use and Associated Factors

    Nutrients . 11(10): 2466. Nº de citas: 7

    [doi:10.3390/nu11102466]

  • Aznar I, Reilev M, Lødrup AB, Rubio-Valera M, Haastrup PF and Pottegård A.

    Use of proton pump inhibitors among Danish children: A 16-year register-based nationwide study

    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY . 124(6): 704-710. Nº de citas: 24

    [doi:10.1111/bcpt.13191]

  • Aznar I, Iglesias M, Rubio-Valera M, Peñarrubia-María MT, Mendive JM, Murrugarra-Centurión AG, Gil MM, González Suñer L, Peuters C and Serrano-Blanco A.

    Diagnostic accuracy and treatment approach to depression in primary care: predictive factors

    FAMILY PRACTICE . 36(1): 3-11. Nº de citas: 3

    [doi:10.1093/fampra/cmy098]

  • Aznar I, Pottegård A, Fernández A, Peñarrubia-María MT, Serrano-Blanco A, Sabés-Figuera R, Gil MM, Fajó-Pascual M, Moreno-Peral P and Rubio-Valera M.

    Effect of copayment policies on initial medication non-adherence according to income: a population-based study.

    BMJ QUALITY & SAFETY . 27(11): 878-891. Nº de citas: 23

    [doi:10.1136/bmjqs-2017-007416]

  • Iglesias M, Aznar I, Peñarrubia-María MT, Gil MM, Fernández-Vergel R, Alonso J, Serrano-Blanco A and Rubio-Valera M.

    Effectiveness of watchful waiting versus antidepressants for patients diagnosed of mild to moderate depression in primary care: A 12-month pragmatic clinical trial (INFAP study).

    EUROPEAN PSYCHIATRY . 53: 66-73. Nº de citas: 10

    [doi:10.1016/j.eurpsy.2018.06.005]

  • Aznar I, Iglesias M, Gil MM, Serrano-Blanco A, Fernández A, Peñarrubia-María MT, Sabés-Figuera R, Murrugarra-Centurión AG, March-Pujol M, Bolívar-Prados M and Rubio-Valera M.

    Impact of initial medication non-adherence to SSRIs on medical visits and sick leaves.

    JOURNAL OF AFFECTIVE DISORDERS . 226: 282-286. Nº de citas: 10

    [doi:10.1016/j.jad.2017.09.057]

  • Iglesias M, Aznar I, Gil MM, Moreno-Peral P, Peñarrubia-María MT, Rubio-Valera M and Serrano-Blanco A.

    Comparing watchful waiting with antidepressants for the management of subclinical depression symptoms to mild-moderate depression in primary care: a systematic review.

    FAMILY PRACTICE . 34(6): 639-648. Nº de citas: 12

    [doi:10.1093/fampra/cmx054]